Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Shenglongda Biotech Group is a Chinese biotechnology company that specializes in the research, development, and production of high-end biological reagents and pharmaceutical intermediates. The company maintains a strong focus on biochemical engineering and often collaborates with academic institutions, including those affiliated with the Chinese Academy of Sciences (CAS). Their product portfolio includes various enzymes, amino acids, and specialized chemical compounds used in both diagnostic and therapeutic applications. Shenglongda operates manufacturing facilities that adhere to international quality standards to serve the global life sciences market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CAS Shanghai Shenglongda Biotech Group.